Grant of Awards under LTIP PDMR Dealing

Eden Research plc (AIM: EDEN), a leader in sustainable biopesticide and biocontrol technology, confirms the grant of 33,737,659 options over new Ordinary Shares under the Company’s Long Term Incentive Plan ("LTIP") to its members of staff (“the Options”)

Of these 7,101,189 Options have been awarded to Sean Smith, Chief Executive Officer and 5,334,928 have been awarded to Alex Abrey, Chief Finance Officer (together the "Executives"). A further 21,301,542 Options have been issued to other employees.

The grant is in respect of CY2025 in order to ensure continuity of long term incentive and is at a strike price of 1p each.

Performance conditions

50% of the grant is subject to an absolute Total Shareholder Return –(share price plus dividends) condition:

This vests in a straight line with 20% of this portion of award vesting at a threshold of 4.36p and increasing up to full vesting at 8.72p;

Share price test is volume weighted average for the final 20 trading days of the two year performance period ending on second anniversary of grant;

50% of the grant is subject to revenue performance target to 31 March 2028 (aggregate audited revenue for FY2027 and FY2028)

Further terms

Awards have a ten year life – i.e. a seven year exercise window;

Following exercise, 50% of the awards are subject to 6 month holding period;